Suppr超能文献

手术切除高危角化细胞癌中完整边缘评估与节段性评估的比较:系统评价和荟萃分析。

Complete Margin Assessment Versus Sectional Assessment in Surgically Excised High-Risk Keratinocyte Carcinomas: A Systematic Review and Meta-Analysis.

机构信息

Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.

School of Arts and Sciences, University of Pennsylvania, Philadelphia, Pennsylvania.

出版信息

Dermatol Surg. 2022 Jul 1;48(7):704-710. doi: 10.1097/DSS.0000000000003462.

Abstract

BACKGROUND

Keratinocyte carcinomas (KCs) are the most diagnosed cancers worldwide and are commonly excised via complete margin assessment (CMA) or excision with sectional assessment (SA). National Comprehensive Cancer Network guidelines encourage CMA for KC with high-risk features.

OBJECTIVE

To systematically compare recurrence outcomes for CMA vs SA in high-risk KC based on National Comprehensive Cancer Network guidelines criteria.

MATERIALS AND METHODS

EMBASE and MEDLINE were searched for articles reporting recurrences of high-risk KC undergoing excision using CMA or SA. High-risk KCs were defined as recurrent, having perineural invasion (PNI), or basal cell carcinomas (BCC) with aggressive histology. Chi-squared tests and risk ratios evaluated differences between CMA and SA groups, and a random-effects meta-analysis was performed.

RESULTS

Twenty-eight studies met inclusion criteria. Pooled percentages of locoregional recurrences were significantly lower with CMA vs SA for all KCs (3.9% [95% CI: 2.9-4.9] vs 13.5% [7.7, 19.2, p = .001]), cutaneous squamous cell carcinoma with PNI (9.8% [5.4-14.1] vs 32.0% [25.0-39.0], p < .001), and recurrent BCC (4.4% [2.9-5.9] vs 11.9% [8.0-15.8], p < .001).

CONCLUSION

For high-risk KCs, recurrence risk was over 3-times greater with SA compared with CMA. Expanded access to CMA for high-risk KC is likely to reduce recurrence risk and improve clinical outcomes.

摘要

背景

角朊细胞癌(KC)是全球最常见的诊断癌症,通常通过完全边缘评估(CMA)或切除分段评估(SA)进行切除。国家综合癌症网络指南鼓励对具有高危特征的 KC 进行 CMA。

目的

根据国家综合癌症网络指南标准,系统比较高危 KC 中 CMA 与 SA 的复发结果。

材料和方法

在 EMBASE 和 MEDLINE 上搜索报道使用 CMA 或 SA 切除高危 KC 后复发的文章。高危 KC 定义为复发、有神经周围侵犯(PNI)或基底细胞癌(BCC)具有侵袭性组织学特征。卡方检验和风险比评估了 CMA 组和 SA 组之间的差异,并进行了随机效应荟萃分析。

结果

28 项研究符合纳入标准。所有 KC(3.9%[95%CI:2.9-4.9]与 13.5%[7.7,19.2,p=.001])、有 PNI 的皮肤鳞状细胞癌(9.8%[5.4-14.1]与 32.0%[25.0-39.0],p<.001)和复发性 BCC(4.4%[2.9-5.9]与 11.9%[8.0-15.8],p<.001)的局灶性复发百分比,CMA 显著低于 SA。

结论

对于高危 KC,SA 的复发风险比 CMA 高 3 倍以上。扩大高危 KC 的 CMA 应用范围可能会降低复发风险并改善临床结果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验